Q-VD-OPH is a broad-spectrum caspase inhibitor that blocks caspases-3, -7, -8, -9, -10, and -12. It more effectively inhibits apoptosis and is much less cytotoxic than Z-VAD-FMK and Boc-D-FMK.
CAT No: R0812
CAS No:1135695-98-5
Synonyms/Alias:1135695-98-5;Q-VD-OPh;Q-VD-OPh hydrate;QVD-OPH;(3S)-5-(2,6-Difluorophenoxy)-3-[[(2S)-3-methyl-1-oxo-2-[(2-quinolinylcarbonyl)amino]butyl]amino]-4-oxo-pentanoic Acid;(3S)-5-(2,6-difluorophenoxy)-3-[[(2S)-3-methyl-2-(quinoline-2-carbonylamino)butanoyl]amino]-4-oxopentanoic acid;(S)-5-(2,6-Difluorophenoxy)-3-((S)-3-methyl-2-(quinoline-2-carboxamido)butanamido)-4-oxopentanoic acid;N-(2-Quinolyl)valyl-aspartyl-(2,6-difluorophenoxy)methyl ketone;pentanoic acid, 5-(2,6-difluorophenoxy)-3-[[(2S)-3-methyl-1-oxo-2-[(2-quinolinylcarbonyl)amino]butyl]amino]-4-oxo-, (3S)-;Quinoline-Val-Asp-Difluorophenoxymethylketone;MFCD08669741;CHEMBL4237988;SCHEMBL15449978;DTXSID90647322;C26H25F2N3O6;CHEBI:232611;EX-A1093;s7311;AKOS027446655;CCG-269797;CS-6252;AC-31505;BS-14641;FD103285;HY-12305;N-(2-Quinolinyl)valyl-aspartyl (2,6-difluorophenoxy)methyl ketone;(3S)-5-(2,6-DIFLUOROPHENOXY)-3-[(2S)-3-METHYL-2-(QUINOLIN-2-YLFORMAMIDO)BUTANAMIDO]-4-OXOPENTANOIC ACID;(3S)-5-(2,6-Difluorophenoxy)-4-oxo-3-{[N-(quinoline-2-carbonyl)-L-valyl]amino}pentanoic acid;
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
5. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.